AstraZeneca (GB:AZN) has released an update.
AstraZeneca PLC has announced that as of September 30, 2024, the total number of voting rights in the company is 1,550,294,658, with all shares currently in circulation. This figure is relevant for shareholders who need to declare changes in their shareholding according to the UK’s Financial Conduct Authority rules. The company, a leader in biopharmaceuticals, specializes in prescription medicines across several key healthcare areas and serves a global market.
For further insights into GB:AZN stock, check out TipRanks’ Stock Analysis page.